Concomitant utilization of XANAX with solid CYP3A inhibitors includes a profound effect on the clearance of alprazolam, leading to elevated concentrations of alprazolam and amplified danger of adverse reactions [see Scientific Pharmacology (twelve.3)]. Prevention or management-The lowest possible helpful dose must be administered and the need for o… Read More